Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,792,449
+$637,124 QoQ
Shares Held
11,097
+12.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#1,697
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IMA Advisory Services, Inc. holds $10,353,187 across 15 Drug Manufacturers - General names. ABBV ranks #1 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
11,097 | $2,792,449 | |
| 2 | JNJ |
Johnson & Johnson
|
10,737 | $2,726,875 | |
| 3 | MRK |
Merck & Co., Inc.
|
20,561 | $2,642,088 | |
| 4 | LLY |
ELI LILLY & Co
|
579 | $694,470 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,115 | $467,586 | |
| 6 | PFE |
Pfizer Inc
|
15,178 | $365,486 | |
| 7 | AZN |
Astrazeneca PLC
|
1,743 | $330,507 | |
| 8 | NVS |
Novartis AG
|
743 | $116,442 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,792,449 | 11,097 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,155,325 | 9,910 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,326,713 | 10,183 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,409,636 | 10,407 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,964,045 | 10,581 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,179,636 | 10,403 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,914,184 | 10,772 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,093,682 | 10,602 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,803,189 | 10,513 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,961,581 | 10,772 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,826,011 | 11,783 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,916,911 | 12,860 | Shares | Sole | 2023-11-28 | |
| 2023-06-30 | $1,829,498 | 13,579 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,224,008 | 13,955 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $2,110,464 | 13,059 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $1,774,256 | 13,220 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $2,063,371 | 13,472 | Shares | Sole | 2022-08-18 | |
| 2022-03-31 | $2,169,518 | 13,383 | Shares | Sole | 2022-06-13 | |
| 2021-12-31 | $2,282,844 | 16,860 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,308,957 | 21,405 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $2,416,015 | 21,449 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,287,337 | 21,136 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,166,573 | 20,220 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,713,260 | 19,560 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,869,052 | 19,037 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,935,683 | 25,406 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||